Related Experiment Video

Updated: Aug 8, 2026

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
11:02

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

Published on: October 31, 2013

Immunoreactive thymosin alpha 1 in human thymus and thymoma

H Naruse1, T Hashimoto, Y Yamakawa

  • 1Second Department of Surgery, Nagoya City University Medical School, Japan.

The Journal of Thoracic and Cardiovascular Surgery
|December 1, 1993
PubMed

Insights

Thymosin alpha 1 levels are higher in thymomas than normal thymuses and vary with histology and lymphocyte infiltration. Levels decrease with age in normal thymuses but not in thymomas.

Area of Science:

  • Immunology
  • Oncology
  • Endocrinology

Background:

  • Thymosin alpha 1 is a peptide hormone involved in T-cell maturation.
  • Its role in thymoma development and progression is not fully understood.

Purpose of the Study:

  • To quantify thymosin alpha 1-like immunoreactivity in human thymus and thymoma tissues.
  • To investigate the relationship between thymosin alpha 1 levels and clinicopathological features of thymoma.

Main Methods:

  • A novel radioimmunoassay utilizing a mouse monoclonal antibody against thymosin alpha 1 was developed.
  • Thymosin alpha 1-like immunoreactivity was measured in normal thymus and thymoma tissue extracts.

Main Results:

  • Thymosin alpha 1-like immunoreactivity was significantly higher in thymomas (273.9 ng/mg protein) compared to normal thymuses (45.0 ng/mg protein).
  • Levels decreased with age in normal thymuses but not in thymomas.
  • Higher levels were observed in polygonal cell thymomas and those with moderate to predominant lymphocyte infiltration.
  • Elevated levels were also noted in thymuses of patients with myasthenia gravis.

Conclusions:

  • Thymosin alpha 1 is upregulated in thymomas, with levels correlating with specific histological subtypes and immune cell infiltration.
  • Age-related decline seen in normal thymuses is absent in thymomas, suggesting altered regulation.
  • Findings may offer insights into thymoma pathogenesis and potential therapeutic targets.

More Related Videos

Isolation, Identification, and Purification of Murine Thymic Epithelial Cells07:20

Isolation, Identification, and Purification of Murine Thymic Epithelial Cells

Published on: August 8, 2014

Characterization of Thymus-dependent and Thymus-independent Immunoglobulin Isotype Responses in Mice Using Enzyme-linked Immunosorbent Assay06:15

Characterization of Thymus-dependent and Thymus-independent Immunoglobulin Isotype Responses in Mice Using Enzyme-linked Immunosorbent Assay

Published on: September 7, 2018

Related Concept Videos

Primary Lymphoid Organs01:16

Primary Lymphoid Organs

Primary lymphoid organs are pivotal in the formation, development, and maturation of lymphocytes, the white blood cells that serve as the backbone of our immune system. This crucial function underscores their fundamental role in maintaining our overall health and immunity. The two primary lymphoid organs of prime importance are the red bone marrow and the thymus.
The red bone marrow is a soft, spongy tissue nestled in the interior of long bones such as the humerus and femur. It is the site...
T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.